GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huadong Medicine Co Ltd (SZSE:000963) » Definitions » Price-to-Operating-Cash-Flow
中文

Huadong Medicine Co (SZSE:000963) Price-to-Operating-Cash-Flow : 14.63 (As of Apr. 25, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Huadong Medicine Co Price-to-Operating-Cash-Flow?

As of today (2024-04-25), Huadong Medicine Co's share price is ¥32.81. Huadong Medicine Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ¥2.24. Hence, Huadong Medicine Co's Price-to-Operating-Cash-Flow Ratio for today is 14.63.

The historical rank and industry rank for Huadong Medicine Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

SZSE:000963' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 11.83   Med: 25.44   Max: 657.38
Current: 14.47

During the past 13 years, Huadong Medicine Co's highest Price-to-Operating-Cash-Flow Ratio was 657.38. The lowest was 11.83. And the median was 25.44.

SZSE:000963's Price-to-Operating-Cash-Flow is ranked better than
58.35% of 677 companies
in the Drug Manufacturers industry
Industry Median: 17.32 vs SZSE:000963: 14.47

Huadong Medicine Co's Cash Flow from Operations per share for the three months ended in Dec. 2023 was ¥0.96. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ¥2.24.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Huadong Medicine Co was 64.80% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 4.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 11.30% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 20.60% per year.

During the past 13 years, Huadong Medicine Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 209.20% per year. The lowest was -58.30% per year. And the median was 21.05% per year.


Huadong Medicine Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Huadong Medicine Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huadong Medicine Co Price-to-Operating-Cash-Flow Chart

Huadong Medicine Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.31 13.62 22.19 34.39 18.48

Huadong Medicine Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.39 33.85 18.43 22.34 18.48

Competitive Comparison of Huadong Medicine Co's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Huadong Medicine Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huadong Medicine Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huadong Medicine Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Huadong Medicine Co's Price-to-Operating-Cash-Flow falls into.



Huadong Medicine Co Price-to-Operating-Cash-Flow Calculation

Huadong Medicine Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=32.81/2.242
=14.63

Huadong Medicine Co's Share Price of today is ¥32.81.
Huadong Medicine Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.24.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Huadong Medicine Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Huadong Medicine Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Huadong Medicine Co (SZSE:000963) Business Description

Traded in Other Exchanges
N/A
Address
468 Yan’an Road, Floor 7, 9 and 10, Gate No. 1, Building No. 1, Hangzhou, CHN, 310006
Huadong Medicine Co Ltd is engaged in the production and sales of antibiotics, proprietary Chinese medicine, chemical synthetic medicine and genetic engineering drugs products. It is also engaged in the wholesale, retail and distribution business of Chinese and western medicine, Chinese herbal medicine, medical apparatus, and instruments. The main business of the company is divided into pharmaceutical business sales and the industry of pharmaceutical. The product portfolio of the company includes Corbrin capsule, Cymusi, New Cyspin, Kasiping, Panlisu, Acarbose, and others.

Huadong Medicine Co (SZSE:000963) Headlines

No Headlines